Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT00418522

Public ClinicalTrials.gov record NCT00418522. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 4:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Six Month, Open Label, Randomized Parallel Group Trial Assessing The Impact Of Dry Powder Inhaled Insulin (Exubera) On Glycemic Control Compared To Insulin Glargine (Lantus) In Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled On A Combination Of Two Or More Oral Agents

Study identification

NCT ID
NCT00418522
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
413 participants

Conditions and interventions

Interventions

  • Inhaled Insulin (Exubera) Drug
  • Insulin glargine Drug

Drug

Eligibility (public fields only)

Age range
30 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2007
Primary completion
Jul 31, 2008
Completion
Jul 31, 2008
Last update posted
Sep 27, 2018

2007 – 2008

United States locations

U.S. sites
72
U.S. states
29
U.S. cities
66
Facility City State ZIP Site status
Pfizer Investigational Site Phoenix Arizona 85051
Pfizer Investigational Site Tucson Arizona 85712
Pfizer Investigational Site Concord California 94520
Pfizer Investigational Site Encino California 91436
Pfizer Investigational Site Fresno California 93720
Pfizer Investigational Site Fullerton California 92835
Pfizer Investigational Site Long Beach California 90806
Pfizer Investigational Site Mission Viejo California 92691
Pfizer Investigational Site Pasadena California 91105
Pfizer Investigational Site San Diego California 92120
Pfizer Investigational Site San Diego California 92128
Pfizer Investigational Site San Luis Obispo California 93401
Pfizer Investigational Site Spring Valley California 91978
Pfizer Investigational Site Stockton California 95204
Pfizer Investigational Site Walnut Creek California 94598
Pfizer Investigational Site West Hills California 91307
Pfizer Investigational Site Golden Colorado 80401
Pfizer Investigational Site Waterbury Connecticut 06708
Pfizer Investigational Site Newark Delaware 19713
Pfizer Investigational Site Chiefland Florida 32626
Pfizer Investigational Site Clearwater Florida 33765
Pfizer Investigational Site Hollywood Florida 33023
Pfizer Investigational Site Kissimmee Florida 34741
Pfizer Investigational Site Miami Florida 33156
Pfizer Investigational Site Ocala Florida 34471
Pfizer Investigational Site Saint Cloud Florida 34769
Pfizer Investigational Site Winter Park Florida 32789
Pfizer Investigational Site Atlanta Georgia 30322
Pfizer Investigational Site Lawrenceville Georgia 30045-3388
Pfizer Investigational Site Lawrenceville Georgia 30045
Pfizer Investigational Site Woodstock Georgia 30189
Pfizer Investigational Site Boise Idaho 83702
Pfizer Investigational Site Hayden Lake Idaho 83835
Pfizer Investigational Site Indianapolis Indiana 46254
Pfizer Investigational Site Overland Park Kansas 66211
Pfizer Investigational Site Topeka Kansas 66606
Pfizer Investigational Site Lexington Kentucky 40503
Pfizer Investigational Site Louisville Kentucky 40213
Pfizer Investigational Site Baton Rouge Louisiana 70808
Pfizer Investigational Site New Orleans Louisiana 70121
Pfizer Investigational Site Haverhill Massachusetts 01830-6141
Pfizer Investigational Site Springfield Missouri 65807
Pfizer Investigational Site Omaha Nebraska 68131
Pfizer Investigational Site Las Vegas Nevada 89104
Pfizer Investigational Site Staten Island New York 10301
Pfizer Investigational Site Charlotte North Carolina 28209-3734
Pfizer Investigational Site Statesville North Carolina 28625
Pfizer Investigational Site Winston-Salem North Carolina 27103
Pfizer Investigational Site Kettering Ohio 45429
Pfizer Investigational Site Maumee Ohio 43537-9402
Pfizer Investigational Site Toledo Ohio 43606
Pfizer Investigational Site Oklahoma City Oklahoma 73103
Pfizer Investigational Site Medford Oregon 97504
Pfizer Investigational Site Melrose Park Pennsylvania 19027
Pfizer Investigational Site Greenville South Carolina 29615
Pfizer Investigational Site Greer South Carolina 29651
Pfizer Investigational Site Spartanburg South Carolina 29303
Pfizer Investigational Site Milan Tennessee 38358
Pfizer Investigational Site Arlington Texas 76014-2010
Pfizer Investigational Site Beaumont Texas 77701
Pfizer Investigational Site Dallas Texas 75230
Pfizer Investigational Site Dallas Texas 75231
Pfizer Investigational Site Dallas Texas 75246
Pfizer Investigational Site El Paso Texas 79935
Pfizer Investigational Site Houston Texas 77008
Pfizer Investigational Site Houston Texas 77083
Pfizer Investigational Site San Antonio Texas 78229-3900
Pfizer Investigational Site San Antonio Texas 78229
Pfizer Investigational Site Bennington Vermont 05201-5018
Pfizer Investigational Site Richmond Virginia 23249
Pfizer Investigational Site Federal Way Washington 98003
Pfizer Investigational Site Menomonee Falls Wisconsin 53051

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00418522, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 27, 2018 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00418522 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →